Vaccines

vax-SPIRAL®

Trivalent Antileptospirosis Vaccine

https://www.finlay.edu.cu/wp-content/uploads/2015/11/vax-SPIRAL.jpg Product

Its use is recommended in people from 15 years of age, whose occupational profile exposes them to risks of acquiring the disease.

vax-MEN-AC®

Polymencharide Antimeningococcal Vaccine A & C

https://www.finlay.edu.cu/wp-content/uploads/2015/11/vax-MEN-AC.jpg Product

For active immunization against meningococcal disease caused by serogroups A and C, in adults and children from two years of age.

vax-TET®

Tetanus Vaccine

https://www.finlay.edu.cu/wp-content/uploads/2015/11/vax-TET.jpg Product

It is recommended for the prevention of tetanus in all ages.

vax-TyVi®

Viral Polysaccharide Antithyroid Vaccine

https://www.finlay.edu.cu/wp-content/uploads/2015/11/vax-TyVi.jpg Product

Prevents typhoid fever in adults and children over 2 years of age.

diTe-vax®

Diphtheria-tetanus Vaccine

https://www.finlay.edu.cu/wp-content/uploads/2015/11/dite-vax.jpg Product

Indicated for the prevention of tetanus and diphtheria in adults, adolescents and children from 7 years of age.

DTP-VAX®

Diphtheria-tetanus-anti-pertussis vaccine

https://www.finlay.edu.cu/wp-content/uploads/2015/11/DTP-VAX.jpg Product

It is indicated for the prevention of tetanus, diphtheria and pertussis in infants and children.

VA-DIFTET®

Diphtheria-Tetanus Vaccine

https://www.finlay.edu.cu/wp-content/uploads/2015/11/VA-DIFTET.jpg Product

Effective to prevent tetanus and diphtheria if a complete and appropriate vaccination is achieved.

VA-MENGOC-BC®

BC Meningococcal Vaccine

https://www.finlay.edu.cu/wp-content/uploads/2015/11/VA-MENGOC-BC.jpg Product

For active immunization against meningococcal disease caused by serogroups B and C.

Proyects

Soporte

Clinical trials.

Attenuated vaccine against cholera (CV638)

Soporte

I+D

Multivalent vaccine against meningococcal disease

Soporte

Clinical trials.

Conjugated vaccine against Streptococcus pneumoniae

Soporte

I+D

Conjugated vaccine against typhoid fever

IFAs

Purified polysaccharide from Neisseria meningitis serogroup C

Active pharmaceutical ingredient for the manufacture of vaccines.

250 mL Bottle

Purified polysaccharide from Neisseria meningitis serogroup A

Active pharmaceutical ingredient for the manufacture of vaccines.

250 mL Bottle

Purified capsular polysaccharide Vi from Salmonella Typhi

Active pharmaceutical ingredient for the manufacture of vaccines.

250 mL Bottle

Inactivated cells of Bordetella Pertussis

Active pharmaceutical ingredient for the manufacture of vaccines.

2L Bottle

Sterile Purified Diphtheria Anatoxin (ADPE)

Active pharmaceutical ingredient for the manufacture of vaccines.

2L Bottle

Sterile Purified Tetanus Anatoxin (ATPE)

Active pharmaceutical ingredient for the manufacture of vaccines.

2L Bottle

Purified polysaccharide from Neisseria meningitis serogroup W135

Active pharmaceutical ingredient for the manufacture of vaccines.

250 mL Bottle

External membrane vesicles of Neisseria meningitis B

Active pharmaceutical ingredient for vaccine manufacturing.

500 mL Bottle